GD2抗体达妥昔单抗β治疗神经母细胞瘤的临床应用专家共识（2021年版）

GD单抗治疗神经母细胞瘤临床应用协作组

Expert consensus on GD2 antibody dinutuximab-β in the treatment of neuroblastoma

Collaborative Group on GD Monoclonal Antibody in the Treatment of Neuroblastoma

临床儿科杂志 . 2022, (1): 14 -20 . DOI: 10.12372/jcp.2022.21e1685